Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model.
Ceyhan
Seyit Temel
ST
Gülhane Military Medical Academy, Department of Obstetrics and Gynecology, GATA Medical School, Ankara, Turkey. stceyhan@gata.edu.tr
Onguru
Onder
O
Fidan
Ulas
U
Ide
Tayfun
T
Yaman
Halil
H
Kilic
Selim
S
Baser
Iskender
I
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001202:Ascitic Fluid / Q000378:metabolism; D004195:Disease Models, Animal; D004715:Endometriosis / Q000188:drug therapy* / Q000473:pathology; D000068800:Etanercept; D005260:Female; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069285:Infliximab; D000077289:Letrozole; D009570:Nitriles / Q000627:therapeutic use*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D000911:Antibodies, Monoclonal; D047072:Aromatase Inhibitors; D007074:Immunoglobulin G; D007155:Immunologic Factors; D009570:Nitriles; D018124:Receptors, Tumor Necrosis Factor; D014230:Triazoles; D042461:Vascular Endothelial Growth Factor A; C467498:vascular endothelial growth factor A, rat; D000077289:Letrozole; D000069285:Infliximab; D000068800:Etanercept